HCW Biologics Correlations

HCWB Stock  USD 0.61  0.16  20.78%   
The current 90-days correlation between HCW Biologics and Shattuck Labs is -0.09 (i.e., Good diversification). The correlation of HCW Biologics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

HCW Biologics Correlation With Market

Good diversification

The correlation between HCW Biologics and DJI is -0.05 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HCW Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.
For information on how to trade HCW Stock refer to our How to Trade HCW Stock guide.

Moving against HCW Stock

  0.31CYRX CryoportPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
PEPGELYM
PMVPRZLT
PHVSRZLT
PEPGANEB
ELYMANEB
PMVPMOLN
  
High negative correlations   
PEPGCYT
PMVPELYM
MNOVMOLN
PEPGPMVP
PEPGRZLT
CYTANEB

Risk-Adjusted Indicators

There is a big difference between HCW Stock performing well and HCW Biologics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze HCW Biologics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ANEB  5.20 (0.27) 0.00 (0.03) 0.00 
 8.85 
 76.00 
RZLT  2.87  0.11  0.05  0.19  3.11 
 6.81 
 30.01 
ELYM  3.92 (0.95) 0.00 (5.36) 0.00 
 6.21 
 34.87 
MOLN  4.66 (0.26) 0.00 (0.11) 0.00 
 9.61 
 52.92 
MNOV  5.11  1.41  0.19 (0.50) 4.17 
 14.50 
 61.30 
CSBR  3.37 (0.04) 0.00  0.09  3.91 
 6.56 
 22.49 
CYT  2.76  0.65  0.13 (0.83) 2.57 
 10.00 
 36.14 
PMVP  1.62  0.02 (0.01) 0.15  2.01 
 3.75 
 13.98 
PHVS  2.95  0.22  0.08  0.29  2.98 
 7.76 
 21.41 
PEPG  3.05 (1.29) 0.00 (0.68) 0.00 
 4.75 
 26.81 

HCW Biologics Corporate Management

Hing WongCEO, FounderProfile
Lee FlowersSenior DevelopmentProfile
Peter RhodeChief OperationsProfile
Nicole EsqVice AffairsProfile